Shares in Astrazeneca have plunged as the FTSE 100 company reported mixed results from a late-stage cancer drug trial.

Daiichi Sankyo Co. shares drop as much as 10.4% on Tuesday, the most since Aug. 5, after its lung cancer drug with ...

Youth unemployment has surged to its highest level in three years, official figures show, dealing a blow to Sir Keir ...

Hiroshima Wada, an analyst at SMBC Nikko Securities Inc., said the result ... said the results were “a bit disappointing”.

Start your day ahead of the curve with our sharp, curated morning news roundup. Get the key stories from top newspapers and ...

Northern Arc Capital's IPO received strong investor interest, getting subscribed 9.98 times on Day 2. The share sale received bids for 21,43,97,349 shares against 2,14,78,290 shares on offer.

Its renowned drug, Darzalex (or daratumumab), came into ... as of the end of the second quarter. Sumitomo Mitsui Financial Group, Inc. (NYSE:SMFG) is engaged in managing financial operations ...

Swift Current Energy (Swift Current), a leading North American clean energy platform, today announced it has closed a $300 million senior secured revolving credit facility. The facility provides Swift ...

Friday's Post Close Movers MIRA Pharmaceuticals said results from a recent study showed its novel ketamine-analog drug proved effective ... coming sessions." Sumitomo Mitsui DS Asset Management ...

Epigenic Therapeutics is developing drugs based on its own gene-editing ... Last year, investors, including SMBC Venture Capital, DG Daiwa Ventures and ANRI, put in ¥200 million ($1.3 million ...